Showing results (341-350 of 351) with videos related to
Sort By:
Pageof 36
Hepatology (Baltimore, Md.)|March 16, 2026
Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazoleNevena Slović, Sumit Mishra, Subhojit Paul, et al.Hepatology (Baltimore, Md.)|May 20, 2024
Deep learning and digital pathology powers prediction of HCC development in steatotic liver diseaseTakuma Nakatsuka, Ryosuke Tateishi, Masaya Sato, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 16, 2013
Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver diseaseYasuji Arase, Yusuke Kawamura, Yuya Seko, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 31, 2026
Guidance for Liver Rehabilitation in Chronic Liver DiseaseShuji Terai, Hiroteru Kamimura, Yoichi Hiasa, et al.Journal of Gastroenterology|October 1, 2020
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter studyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.Journal of Gastroenterology|June 20, 2025
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosisNaoki Kawagishi, Goki Suda, Yuki Tahata, et al.Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.Journal of Gastroenterology|October 13, 2023
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virusYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2024
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.Journal of Gastroenterology|May 12, 2026
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026Norio Akuta, Tomomi Kogiso, Kenichi Ikejima, et al.Pageof 36